See Atopica At Work











Review this article to learn more about the long-term solution for this life-long disease.

ATOPICA™ (cyclosporine capsules) USP MODIFIED is indicated for the control of atopic dermatitis in dogs weighing at least 4 pounds.

Important Safety Information
Do not use Atopica in dogs with a history of neoplasia, with a hypersensitivity to cyclosporine, or in reproducing dogs. Atopica is a systemic immunosuppressant that may increase susceptibility to infection and development of neoplasia. For use only in dogs. Capsules should not be broken or opened. Wear gloves during administration and wash hands after administration. Gastrointestinal problems and gingival hyperplasia may occur at the initial dose. Safety and effectiveness has not been established in dogs less than 6 months or 4 lbs. Use with caution in dogs with diabetes mellitus or renal insufficiency, and with drugs that affect the P-450 pathway. Killed vaccines are recommended. The most common adverse events are vomiting and diarrhea. Please see product insert full prescribing information.

Sign-up for Updates

Stay current with conditions like atopic dermatitis




SHARE THIS PAGE WITH A COLLEAGUE!

ATO-Logo-Dogs.png


1. Forsythe P, Paterson S. 2014. "Ciclosporin 10 years on: indications and efficacy." Vet Rec. 174 Suppl 2:13-21.


Elanco Animal HealthAtopica, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.  Clinician's Brief™ and clinicalnotes™ is a trademark of Educational Concepts, L.L.C. dba Brief Media™
©2018 Elanco or its affiliates.

Privacy Statement | Terms of Use | Contact Us

PM-US-18-0316